Announced on | Meeting on |
Aug 05, 2024 | Aug 12, 2024 |
Quarterly Results | |
May 08, 2024 | May 20, 2024 |
Audited Results | |
Jan 29, 2024 | Feb 09, 2024 |
Quarterly Results | |
Oct 25, 2023 | Nov 06, 2023 |
Quarterly Results | |
Aug 01, 2023 | Aug 11, 2023 |
Quarterly Results |
Camlin Fine Sciences Share Price
- Open103.70
- High104.85
- Low102.65
- Prev Close103.20
- Volume3,21,037
- VWAP(₹)103.73
Camlin Fine Sc share price insights
PAT: Troublesome Times
Company has posted a loss of Rs 33.95 cr for the 4th consecutive quarter. (Source: Consolidated Financials)Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of -39.58% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)Topline Contraction
Sales de-grew by 3.48%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Consolidated Financials)Employee & Interest Expense
Company has spent 3.74% of its operating revenues towards interest expenses and 11.08% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)Camlin Fine Sc Share Price Update
Camlin Fine Sciences Ltd. share price moved up by 0.09% from its previous close of Rs 103.20. Camlin Fine Sciences Ltd. stock last traded price is 103.29
Share Price Value Today/Current/Last 103.29 Previous Day 103.20
Camlin Fine Sc Share Price Returns
1 Day | 0.09% |
1 Month | -13.11% |
3 Months | 9.71% |
1 Year | -37.04% |
3 Years | -40.66% |
5 Years | 86.44% |
Key Metrics
PE Ratio(x) | -12.24 |
EPS - TTM(₹) | -8.49 |
MCap(₹ Cr.) | 1,741.62 |
MCap Rank | 50 |
PB Ratio(x) | 2.02 |
Div Yield(%) | 0.00 |
Face Value(₹) | 1.00 |
52W High(₹) | 186.35 |
52W Low(₹) | 79.95 |
MCap/Sales | 0.93 |
Beta(1 Month) | 2.41 |
BV/Share(₹) | 51.16 |
Camlin Fine Sc Share Recommendations
2 Analysts
SellSellHoldBuyStrong
Buy
Ratings | Current | 1W Ago | 1M Ago | 3M Ago |
---|---|---|---|---|
Strong Buy | - | - | 1 | 1 |
Buy | 1 | 1 | - | - |
Hold | 1 | 1 | 1 | 1 |
Sell | - | - | - | - |
Strong Sell | - | - | - | - |
# Analysts | 2 | 2 | 2 | 2 |
Camlin Fine Sc News & Analysis
NewsCamlin Fine Sciences shares surge 9% after company announces 1 Euro acquisition
NewsPharma firm finds energy to eye 7% rise; chemical maker raises the bar to 9%
NewsDiwali doublers: InCred gunning for 3 stocks that can gain up to 311% in 3 years Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (S..
Announcements
Camlin Fine Sc Financials
Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Total Income 397.72 407.46 387.55 407.64 425.97 Total Income Growth (%) -2.39 5.14 -4.93 -4.30 -0.64 Total Expenses 397.83 484.80 383.14 399.95 399.67 Total Expenses Growth (%) -17.94 26.53 -4.20 0.07 -2.64 EBIT -0.11 -77.34 4.41 7.69 26.30 EBIT Growth (%) - -1,854.09 -42.69 -70.75 44.43 Profit after Tax (PAT) -33.95 -77.14 -11.79 -19.38 15.55 PAT Growth (%) - - - -224.61 69.80 EBIT Margin (%) -0.03 -18.98 1.14 1.89 6.17 Net Profit Margin (%) -8.54 -18.93 -3.04 -4.75 3.65 Basic EPS (₹) -2.03 -4.64 -0.71 -1.17 0.96 All figures in Rs Cr, unless mentioned otherwise
InsightsPAT: Troublesome Times
Company has posted a loss of Rs 33.95 cr for the 4th consecutive quarter. (Source: Consolidated Financials)Topline Contraction
Sales de-grew by 3.48%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Consolidated Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Total Assets 1,951.72 2,060.10 1,800.08 1,481.60 1,234.06 Total Assets Growth (%) -5.26 14.44 21.50 20.06 13.55 Total Liabilities 1,094.77 1,236.01 1,035.03 768.45 773.96 Total Liabilities Growth (%) -11.43 19.42 34.69 -0.71 17.89 Total Equity 853.64 820.77 761.74 709.84 456.80 Total Equity Growth (%) 4.00 7.75 7.31 55.40 6.99 Current Ratio (x) 1.37 1.37 1.50 1.66 1.23 Total Debt to Equity (x) 0.81 1.04 0.94 1.00 1.22 Contingent Liabilities 51.62 44.99 53.61 125.63 10.55 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Net Cash flow from Operating Activities 138.98 50.90 145.45 117.38 86.02 Net Cash used in Investing Activities -66.50 -124.63 -249.13 -132.86 -90.12 Net Cash flow from Financing Activities -85.97 59.66 135.97 38.63 3.25 Net Cash Flow -13.49 -14.07 32.29 23.15 -0.85 Closing Cash & Cash Equivalent 80.25 93.74 107.81 75.52 52.37 Closing Cash & Cash Equivalent Growth (%) -14.39 -13.05 42.76 44.21 -1.59 Total Debt/ CFO (x) 4.73 15.32 4.28 4.58 5.69 All figures in Rs Cr, unless mentioned otherwise
InsightsDecrease in Cash from Investing
Company has used Rs 66.5 cr for investing activities which is an YoY decrease of 46.64%. (Source: Consolidated Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Return on Equity (%) -11.35 6.92 9.16 9.43 7.58 Return on Capital Employed (%) 0.89 11.72 10.77 14.20 14.76 Return on Assets (%) -4.75 2.52 3.37 3.43 2.45 Interest Coverage Ratio (x) 1.48 3.61 5.20 4.98 2.35 Asset Turnover Ratio (x) 0.80 0.47 0.48 0.52 85.01 Price to Earnings (x) -16.13 38.46 36.10 35.09 15.77 Price to Book (x) 1.83 2.66 3.31 3.30 1.19 EV/EBITDA (x) 22.92 12.72 14.46 12.05 7.15 EBITDA Margin (%) 5.54 12.55 13.16 15.74 12.78
Peer Comparison
NAME 1D 1W 1M 3M 1Y 3Y 5Y Camlin Fine Sc Stock Performance 0.59 -3.95 -14.12 9.32 -36.38 -39.23 88.38 S H Kelkar & Co. Stock Performance -0.97 9.52 27.26 29.30 52.63 67.34 92.24 Meghmani Organics Stock Performance 0.19 0.18 18.13 27.83 20.76 -8.93 0.00 Yasho Industries Stock Performance -2.10 5.81 2.69 8.04 15.19 0.00 0.00 Tatva Chintan Pharma Chem Stock Performance -1.13 -6.60 -4.00 -10.61 -45.44 -53.96 0.00 All values in %
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of -39.58% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)
Mutual Funds Ownership
MF Ownership as on 31 July 2024
51.91
Amount Invested (in Cr.)
0.59%
% of AUM
0.00
% Change (MoM basis)
ICICI Pru Commodities Direct-G
Equity: Thematic
28.06
Amount Invested (in Cr.)
1.07%
% of AUM
0.00
% Change (MoM basis)
ICICI Pru Dividend Yield Equity Direct-G
Equity: Thematic-Dividend Yield
2.72
Amount Invested (in Cr.)
0.06%
% of AUM
0.00
% Change (MoM basis)
Corporate Actions
Board Meeting
Quarterly Results
Aug 05, 2024
Board Meeting
Audited Results
May 08, 2024
Board Meeting
Quarterly Results
Jan 29, 2024
Announced on Ex-Date Dividend% May 23, 2016 Jul 28, 2016 45% May 12, 2015 Jul 27, 2015 45% May 29, 2014 Jul 24, 2014 35% May 21, 2013 Aug 01, 2013 30% May 24, 2012 Jul 23, 2012 25% No Data Available
Announced on Ex-Date Jun 17, 2014 Sep 04, 2014 Split: Old FV2.0| New FV:1.0 Nov 10, 2011 Feb 15, 2012 Split: Old FV10.0| New FV:2.0 Announced on Ex-Date Dec 01, 2009 Jul 30, 2010 Rights ratio: 3 share for every 5 held at a price of Rs 15.75 Announced on Meeting on May 23, 2023 Jul 31, 2023 A.G.M. May 19, 2022 Jul 29, 2022 Book closure from Jul 23, 2022 to Jul 29, 2022 Feb 24, 2022 Mar 28, 2022 - May 28, 2021 Aug 13, 2021 Book closure from Aug 7, 2021 to Aug 13, 2021 May 28, 2021 - (Revised)
About
Camlin Fine Sciences Ltd., incorporated in the year 1993, is a Small Cap company (having a market cap of Rs 1,728.55 Crore) operating in Chemicals sector.
Camlin Fine Sciences Ltd. key Products/Revenue Segments include Speciality Chemicals, Service Income, Scrap for the year ending 31-Mar-2024.
For the quarter ended 30-06-2024, the company has reported a Consolidated Total Income of Rs 397.72 Crore, down 2.39 % from last quarter Total Income of Rs 407.46 Crore and down 6.63 % from last year same quarter Total Income of Rs 425.97 Crore. Company has reported net profit after tax of Rs -34.65 Crore in latest quarter.
The company’s top management includes Mr.Ashish Dandekar, Mr.Nirmal Momaya, Mr.Arjun Dukane, Ms.Anagha Dandekar, Mr.Harsha Raghavan, Mr.Amol Shah, Mr.Joseph Conrad D'souza, Mr.Mahabaleshwar Palekar, Mr.Pradip Kanakia, Mr.Sutapa Banerjee, Mr.Santosh Parab, Mr.Rahul Sawale. Company has Kalyaniwalla & Mistry LLP as its auditors. As on 30-06-2024, the company has a total of 16.75 Crore shares outstanding.
About Camlin Fine Sc
Camlin Fine Sciences Ltd., incorporated in the year 1993, is a Small Cap company (having a market cap of Rs 1,728.55 Crore) operating in Chemicals sector. Camlin Fine Sciences Ltd. key Products/Revenue Segments include Speciality Chemicals, Service Income, Scrap for the year ending 31-Mar-2024.For the quarter ended 30-06-2024, the company has reported a Consolidated Total Income of Rs 397.72 Crore, down 2.39 % from last quarter Total Income of Rs 407.46 Crore and down 6.63 % from last year same quarter Total Income of Rs 425.97 Crore. Company has reported net profit after tax of Rs -34.65 Crore in latest quarter.The company’s top management includes Mr.Ashish Dandekar, Mr.Nirmal Momaya, Mr.Arjun Dukane, Ms.Anagha Dandekar, Mr.Harsha Raghavan, Mr.Amol Shah, Mr.Joseph Conrad D'souza, Mr.Mahabaleshwar Palekar, Mr.Pradip Kanakia, Mr.Sutapa Banerjee, Mr.Santosh Parab, Mr.Rahul Sawale. Company has Kalyaniwalla & Mistry LLP as its auditors. As on 30-06-2024, the company has a total of 16.75 Crore shares outstanding.
Industry
Key Indices Listed On
BSE SmallCap, BSE Commodities, BSE AllCap, Nifty Microcap 250, Nifty Total Market
Address
Floor 2 to 5, In GS Point,CST Road, Kalina,Santacruz East,Mumbai, Maharashtra - 400098
Executive Leadership
Ashish Dandekar
Chairman & Managing DirectorNirmal Momaya
Managing DirectorArjun Dukane
Executive Director -TechnicalAnagha Dandekar
Non Exe.Non Ind.DirectorAuditors
Trending in Markets
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.